Silvercrest Asset Management Group LLC Sells 114,218 Shares of Humana Inc. (NYSE:HUM)

Silvercrest Asset Management Group LLC decreased its position in Humana Inc. (NYSE:HUM - Free Report) by 92.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 9,170 shares of the insurance provider's stock after selling 114,218 shares during the period. Silvercrest Asset Management Group LLC's holdings in Humana were worth $2,327,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. FPC Investment Advisory Inc. bought a new stake in Humana in the fourth quarter valued at $27,000. Centricity Wealth Management LLC bought a new stake in Humana in the fourth quarter valued at $30,000. LFA Lugano Financial Advisors SA boosted its holdings in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new stake in Humana in the fourth quarter valued at $33,000. Finally, Transce3nd LLC bought a new stake in Humana in the fourth quarter valued at $38,000. Institutional investors own 92.38% of the company's stock.

Humana Price Performance

Shares of NYSE:HUM opened at $247.16 on Tuesday. Humana Inc. has a fifty-two week low of $212.45 and a fifty-two week high of $406.46. The business has a 50-day simple moving average of $262.90 and a two-hundred day simple moving average of $269.48. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market cap of $29.83 billion, a price-to-earnings ratio of 24.84, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The business had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same quarter in the previous year, the firm earned $7.23 EPS. Humana's revenue was up 8.4% on a year-over-year basis. On average, analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio (DPR) is 25.04%.

Analysts Set New Price Targets

HUM has been the topic of several recent analyst reports. JPMorgan Chase & Co. cut their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Cantor Fitzgerald restated a "neutral" rating and set a $290.00 target price on shares of Humana in a report on Thursday, May 1st. Guggenheim assumed coverage on shares of Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price on the stock. StockNews.com upgraded shares of Humana from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Robert W. Baird boosted their target price on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Seventeen research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $286.81.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.